BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants (BCTXZ) Live Share Price, Invest From India

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock Performance

as on July 11, 2026 at 2:15 pm IST

Day's Low
$0.09
Day's Price Range
$0.10
$0.10
10.00%
Downside
52 Week's Low
52 Week's High
$0.06
52-Week Price Range
$0.70
$0.10
44.90%
Downside
599.90%
Upside

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share price movements today

Previous Close: $0.10
Open: $0.10
Volume: 1.1M
Day's Low - High: $0.09 - $0.10
52 Week Low - High: $0.06 - $0.70

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Historical Returns

1 Month Return: + 25.03 %
3 Month Return: -33.4 %
1 Year Return: -80.02 %
3 Year Return: 0 %
5 Year Return: 0 %

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock Fundamentals & Key Indicators

Check BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-175.26%

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants	NA	$-	NA	NA	0.00%	NA
Insmed Inc.	BUY	$25.6B	307.08%	NA	-144.44%	NA
Alnylam Pharmaceuticals Inc.	BUY	$41.8B	69.04%	81.24	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$126.0B	144.95%	29.59	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$70.0B	14.49%	16.18	29.65%	0.54%

Stock Returns calculator for BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock including INR - Dollar returns

The BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants investment value today

Current value as on today

₹22,249

Returns

-₹77,751

(-77.75%)

Returns from BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock

-₹80,000 (-80%)

Dollar Impact

₹2,249 (+2.25%)

Indian Investors' Interest in BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock

Search interest for BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 11, 2026 to July 11, 2026

Change:8% versus previous 30 day period

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Quarterly Profit & Loss

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Oct 2025	Jan 2026	Apr 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	-	0	0	-
Operating Income	-9	-9	-5	-5	-7	-6	-8	-7	-7
EBITDA	-9	-9	-5	-5	-7	-6	-8	-7	-7
Interest Expense	-	-	-	-	-	0	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	1	-1	-5	-6	-6	-8	-7	-7
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-11	1	-1	-5	-6	-6	-8	-7	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Annual Profit & Loss

All numbers in Millions USD

	Jul 2021	Jul 2022	Jul 2023	Jul 2024
Total Revenue	-	-	-	-
Gross Profit	0	0	0	0
Operating Income	-7	-15	-23	-33
EBITDA	-7	-26	-23	-4
Interest Expense	0	0	-	-
Depreciation	0	0	0	0
Income Before Tax	-13	-26	-20	-4
Income Tax Expense	6	0	0	-
Net Income	-13	-26	-20	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Quarterly Cash Flow

All numbers in Millions USD

	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026	Apr 2026
Net Income	1	-1	-5	-6	-6	-8	-8	-7	-7
Operating Cash Flow	-4	-4	-6	-5	-7	-8	-7	-7	-7
Investing Cash Flow	0	0	0	0	0	-7	0	7	-16
Financing Cash Flow	-	4	11	5	14	13	-	27	0
Change in Cash	-5	0	4	0	7	-1	-7	27	-22

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Annual Cash Flow

All numbers in Millions USD

	Jul 2017	Jul 2018	Jul 2019	Jul 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024	Jul 2025
Net Income	-3	-5	-5	-4	-13	-26	-20	-4	-26
Operating Cash Flow	-1	-4	-5	-1	-7	-12	-23	-24	-28
Investing Cash Flow	0	0	1	-	-	-	-	0	-7
Financing Cash Flow	2	5	2	1	64	-3	3	4	46
Change in Cash	1	0	0	0	57	-16	-19	-20	9

Insights on BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, BCTXZ stock has moved down by -26.4%

About BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Organisation	BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants
Headquarters	Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Industry	Miscellaneous
CEO	Dr. William V. Williams FCPA, M.D.
E-voting on shares	Click here to vote

Key Management of BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants

Name	Title
Dr. William V. Williams FCPA, M.D.	CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H.	Chief Medical Officer
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board

FAQs

What is BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share price today?

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share price today is $0.10 as on July 11, 2026 at 8:45 am IST at the close of the market. BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share today touched a day high of $0.10 and a low of $0.09.

What is the 52 week high and 52 week low for BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share?

BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share touched a 52 week high of $0.70 on July 11, 2025 and a 52 week low of $0.06 on March 9, 2026. BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants stock price today i.e. July 11, 2026 at 8:45 am IST is closed at $0.10,which is 85.71% down from its 52 week high and 81.49% up from its 52 week low.

How to invest in BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock (BCTXZ) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Shares that will get you 15.0000 shares as per BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share price of $0.10 per share as on July 11, 2026 at 8:45 am IST.

What is the minimum amount required to buy BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants Stock (BCTXZ) from India?

Indian investors can start investing in BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants (BCTXZ) shares with as little as ₹95.315 or $1 (as of July 11, 2026 at 10:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.15 in BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants stock (as per the Rupee-Dollar exchange rate as on July 11, 2026 at 10:38 am IST). Based on BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants share’s latest price of $0.10 as on July 11, 2026 at 8:45 am IST, you will get 100.0000 shares of BriaCell Therapeutics Corp. Warrant expiring 2030 Warrants. Learn more about fractional shares .